NeoProfen (ibuprofen lysine) Solution
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
January 2016
ADVERSE REACTIONS
Post marketing Experience
*added term Pulmonary hypertension
...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts